New cancer drugs are expensive and often ineffective

Brussels Times

5 July 2021 - Many of the new cancer drugs coming onto the market in Belgium are too expensive, and often ineffective, according to a new report from the Belgian Health Care Knowledge Centre.

The report, titled in English ‘Do innovative medicines against cancer always have a real added value?’ looks at two main issues: how anti-cancer drugs are supported by the arrangements in force to approve them and then make the cost reimbursable by health insurance. 

And then: does the effect of the drugs justify the cost, as well as the hope given to the patients.

Read Brussels Times article

Michael Wonder

Posted by:

Michael Wonder